The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.
The authors of a new study investigated the long-term risk for adulthood end-stage renal disease among individuals who had childhood kidney disease that resolved prior to adolescence.
Patients with end stage renal disease on hemodialysis experience high 30-day unplanned readmissions. Using a large administrative database, researchers investigated reasons for initial admission and...
A study examined the potential of a prognostic tool that could better identify patients with type 1 or type 2 diabetes at risk for end stage renal disease.
Researchers examined the effects of a diet high in potassium on the risk of decline in renal function and cardiovascular disease in patients with type 2 diabetes.
